nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A7—Methotrexate—esophageal cancer	0.158	0.43	CbGbCtD
Zalcitabine—CYP2C9—Capecitabine—esophageal cancer	0.0944	0.257	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—esophageal cancer	0.0672	0.183	CbGbCtD
Zalcitabine—CYP2C9—Cisplatin—esophageal cancer	0.0476	0.129	CbGbCtD
Zalcitabine—Lamivudine—ABCC2—esophageal cancer	0.00229	0.564	CrCbGaD
Zalcitabine—Inflammation—Capecitabine—esophageal cancer	0.00128	0.00351	CcSEcCtD
Zalcitabine—Coordination abnormal—Capecitabine—esophageal cancer	0.00127	0.00347	CcSEcCtD
Zalcitabine—Neck pain—Capecitabine—esophageal cancer	0.00126	0.00345	CcSEcCtD
Zalcitabine—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00125	0.00341	CcSEcCtD
Zalcitabine—Stupor—Methotrexate—esophageal cancer	0.00124	0.0034	CcSEcCtD
Zalcitabine—Hyponatraemia—Cisplatin—esophageal cancer	0.00123	0.00337	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00123	0.00336	CcSEcCtD
Zalcitabine—Melaena—Capecitabine—esophageal cancer	0.00122	0.00333	CcSEcCtD
Zalcitabine—Influenza like illness—Capecitabine—esophageal cancer	0.00121	0.00331	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Capecitabine—esophageal cancer	0.0012	0.00329	CcSEcCtD
Zalcitabine—Colitis—Capecitabine—esophageal cancer	0.0012	0.00327	CcSEcCtD
Zalcitabine—Skin ulcer—Methotrexate—esophageal cancer	0.00119	0.00326	CcSEcCtD
Zalcitabine—Skin exfoliation—Capecitabine—esophageal cancer	0.00119	0.00325	CcSEcCtD
Zalcitabine—Candida infection—Capecitabine—esophageal cancer	0.00119	0.00325	CcSEcCtD
Zalcitabine—Gingivitis—Methotrexate—esophageal cancer	0.00118	0.00323	CcSEcCtD
Zalcitabine—Dry eye—Capecitabine—esophageal cancer	0.00115	0.00315	CcSEcCtD
Zalcitabine—Blood creatinine increased—Cisplatin—esophageal cancer	0.00115	0.00314	CcSEcCtD
Zalcitabine—Oesophagitis—Capecitabine—esophageal cancer	0.00114	0.00311	CcSEcCtD
Zalcitabine—Urine output increased—Capecitabine—esophageal cancer	0.00113	0.00308	CcSEcCtD
Zalcitabine—Hypokalaemia—Cisplatin—esophageal cancer	0.00112	0.00305	CcSEcCtD
Zalcitabine—Cramp muscle—Cisplatin—esophageal cancer	0.0011	0.00302	CcSEcCtD
Zalcitabine—Nasopharyngitis—Cisplatin—esophageal cancer	0.0011	0.003	CcSEcCtD
Zalcitabine—Abnormal vision—Capecitabine—esophageal cancer	0.00109	0.00297	CcSEcCtD
Zalcitabine—Mental disability—Capecitabine—esophageal cancer	0.00108	0.00296	CcSEcCtD
Zalcitabine—Speech disorder—Methotrexate—esophageal cancer	0.00108	0.00295	CcSEcCtD
Zalcitabine—Ear pain—Capecitabine—esophageal cancer	0.00106	0.0029	CcSEcCtD
Zalcitabine—Diabetes mellitus—Capecitabine—esophageal cancer	0.00104	0.00284	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00104	0.00284	CcSEcCtD
Zalcitabine—Pancreatitis—Cisplatin—esophageal cancer	0.00104	0.00284	CcSEcCtD
Zalcitabine—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00103	0.00283	CcSEcCtD
Zalcitabine—Sweating increased—Cisplatin—esophageal cancer	0.00103	0.00283	CcSEcCtD
Zalcitabine—Polyuria—Capecitabine—esophageal cancer	0.00103	0.00282	CcSEcCtD
Zalcitabine—Swelling—Capecitabine—esophageal cancer	0.00102	0.0028	CcSEcCtD
Zalcitabine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00102	0.00279	CcSEcCtD
Zalcitabine—Deafness—Capecitabine—esophageal cancer	0.00101	0.00276	CcSEcCtD
Zalcitabine—Vascular purpura—Capecitabine—esophageal cancer	0.00101	0.00276	CcSEcCtD
Zalcitabine—Glossitis—Methotrexate—esophageal cancer	0.00101	0.00275	CcSEcCtD
Zalcitabine—Eye pain—Capecitabine—esophageal cancer	0.001	0.00274	CcSEcCtD
Zalcitabine—Hyperuricaemia—Methotrexate—esophageal cancer	0.001	0.00273	CcSEcCtD
Zalcitabine—Ulcer—Methotrexate—esophageal cancer	0.00098	0.00268	CcSEcCtD
Zalcitabine—Renal failure acute—Capecitabine—esophageal cancer	0.000979	0.00268	CcSEcCtD
Zalcitabine—Libido decreased—Capecitabine—esophageal cancer	0.000975	0.00267	CcSEcCtD
Zalcitabine—Hot flush—Capecitabine—esophageal cancer	0.000967	0.00264	CcSEcCtD
Zalcitabine—Amnesia—Capecitabine—esophageal cancer	0.000962	0.00263	CcSEcCtD
Zalcitabine—Menopausal symptoms—Capecitabine—esophageal cancer	0.000958	0.00262	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000958	0.00262	CcSEcCtD
Zalcitabine—Inflammation—Methotrexate—esophageal cancer	0.000956	0.00262	CcSEcCtD
Zalcitabine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000954	0.00261	CcSEcCtD
Zalcitabine—Renal impairment—Capecitabine—esophageal cancer	0.00095	0.0026	CcSEcCtD
Zalcitabine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000946	0.00259	CcSEcCtD
Zalcitabine—Blood uric acid increased—Methotrexate—esophageal cancer	0.000944	0.00258	CcSEcCtD
Zalcitabine—Purpura—Capecitabine—esophageal cancer	0.000938	0.00257	CcSEcCtD
Zalcitabine—Arthritis—Capecitabine—esophageal cancer	0.00093	0.00254	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000927	0.00253	CcSEcCtD
Zalcitabine—Cardiac failure—Capecitabine—esophageal cancer	0.000927	0.00253	CcSEcCtD
Zalcitabine—Gemcitabine—ABCB1—esophageal cancer	0.000926	0.228	CrCbGaD
Zalcitabine—Hyponatraemia—Capecitabine—esophageal cancer	0.000908	0.00248	CcSEcCtD
Zalcitabine—Melaena—Methotrexate—esophageal cancer	0.000906	0.00248	CcSEcCtD
Zalcitabine—Pain in extremity—Capecitabine—esophageal cancer	0.000904	0.00247	CcSEcCtD
Zalcitabine—Osteoarthritis—Capecitabine—esophageal cancer	0.000904	0.00247	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000904	0.00247	CcSEcCtD
Zalcitabine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000897	0.00245	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.000895	0.00245	CcSEcCtD
Zalcitabine—Migraine—Capecitabine—esophageal cancer	0.00089	0.00243	CcSEcCtD
Zalcitabine—Skin exfoliation—Methotrexate—esophageal cancer	0.000885	0.00242	CcSEcCtD
Zalcitabine—Vaginal infection—Methotrexate—esophageal cancer	0.000875	0.00239	CcSEcCtD
Zalcitabine—Urinary retention—Capecitabine—esophageal cancer	0.00086	0.00235	CcSEcCtD
Zalcitabine—Mood swings—Capecitabine—esophageal cancer	0.000857	0.00234	CcSEcCtD
Zalcitabine—Ataxia—Capecitabine—esophageal cancer	0.00085	0.00233	CcSEcCtD
Zalcitabine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000847	0.00232	CcSEcCtD
Zalcitabine—Lamivudine—ABCB1—esophageal cancer	0.000843	0.208	CrCbGaD
Zalcitabine—Urine output increased—Methotrexate—esophageal cancer	0.000838	0.00229	CcSEcCtD
Zalcitabine—Bladder pain—Methotrexate—esophageal cancer	0.000838	0.00229	CcSEcCtD
Zalcitabine—Dry skin—Capecitabine—esophageal cancer	0.000829	0.00227	CcSEcCtD
Zalcitabine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000826	0.00226	CcSEcCtD
Zalcitabine—Hypokalaemia—Capecitabine—esophageal cancer	0.000823	0.00225	CcSEcCtD
Zalcitabine—Visual impairment—Cisplatin—esophageal cancer	0.000818	0.00224	CcSEcCtD
Zalcitabine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000809	0.00221	CcSEcCtD
Zalcitabine—Gastritis—Capecitabine—esophageal cancer	0.0008	0.00219	CcSEcCtD
Zalcitabine—Muscular weakness—Capecitabine—esophageal cancer	0.000797	0.00218	CcSEcCtD
Zalcitabine—Eye disorder—Cisplatin—esophageal cancer	0.000793	0.00217	CcSEcCtD
Zalcitabine—Tinnitus—Cisplatin—esophageal cancer	0.000791	0.00216	CcSEcCtD
Zalcitabine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000789	0.00216	CcSEcCtD
Zalcitabine—Flushing—Cisplatin—esophageal cancer	0.000788	0.00215	CcSEcCtD
Zalcitabine—Abdominal distension—Capecitabine—esophageal cancer	0.000787	0.00215	CcSEcCtD
Zalcitabine—Dysphagia—Capecitabine—esophageal cancer	0.000781	0.00214	CcSEcCtD
Zalcitabine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000774	0.00212	CcSEcCtD
Zalcitabine—Polyuria—Methotrexate—esophageal cancer	0.000767	0.0021	CcSEcCtD
Zalcitabine—Sweating increased—Capecitabine—esophageal cancer	0.000761	0.00208	CcSEcCtD
Zalcitabine—Arrhythmia—Cisplatin—esophageal cancer	0.000758	0.00207	CcSEcCtD
Zalcitabine—Alopecia—Cisplatin—esophageal cancer	0.00075	0.00205	CcSEcCtD
Zalcitabine—Neutropenia—Capecitabine—esophageal cancer	0.000731	0.002	CcSEcCtD
Zalcitabine—Dysuria—Capecitabine—esophageal cancer	0.000731	0.002	CcSEcCtD
Zalcitabine—Renal failure acute—Methotrexate—esophageal cancer	0.000729	0.00199	CcSEcCtD
Zalcitabine—Flatulence—Cisplatin—esophageal cancer	0.000728	0.00199	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000713	0.00195	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000713	0.00195	CcSEcCtD
Zalcitabine—Muscle spasms—Cisplatin—esophageal cancer	0.00071	0.00194	CcSEcCtD
Zalcitabine—Weight decreased—Capecitabine—esophageal cancer	0.000707	0.00193	CcSEcCtD
Zalcitabine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000705	0.00193	CcSEcCtD
Zalcitabine—Vision blurred—Cisplatin—esophageal cancer	0.000696	0.0019	CcSEcCtD
Zalcitabine—Depression—Capecitabine—esophageal cancer	0.000695	0.0019	CcSEcCtD
Zalcitabine—Tremor—Cisplatin—esophageal cancer	0.000692	0.00189	CcSEcCtD
Zalcitabine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000685	0.00187	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000683	0.00187	CcSEcCtD
Zalcitabine—Anaemia—Cisplatin—esophageal cancer	0.000683	0.00187	CcSEcCtD
Zalcitabine—Jaundice—Capecitabine—esophageal cancer	0.000679	0.00186	CcSEcCtD
Zalcitabine—Osteoarthritis—Methotrexate—esophageal cancer	0.000673	0.00184	CcSEcCtD
Zalcitabine—Malaise—Cisplatin—esophageal cancer	0.000666	0.00182	CcSEcCtD
Zalcitabine—Leukopenia—Cisplatin—esophageal cancer	0.000661	0.00181	CcSEcCtD
Zalcitabine—Epistaxis—Capecitabine—esophageal cancer	0.000657	0.0018	CcSEcCtD
Zalcitabine—Convulsion—Cisplatin—esophageal cancer	0.00064	0.00175	CcSEcCtD
Zalcitabine—Mood swings—Methotrexate—esophageal cancer	0.000638	0.00174	CcSEcCtD
Zalcitabine—Ataxia—Methotrexate—esophageal cancer	0.000633	0.00173	CcSEcCtD
Zalcitabine—Myalgia—Cisplatin—esophageal cancer	0.000629	0.00172	CcSEcCtD
Zalcitabine—Rhinitis—Capecitabine—esophageal cancer	0.000627	0.00172	CcSEcCtD
Zalcitabine—Anxiety—Cisplatin—esophageal cancer	0.000627	0.00171	CcSEcCtD
Zalcitabine—Hepatitis—Capecitabine—esophageal cancer	0.000626	0.00171	CcSEcCtD
Zalcitabine—Discomfort—Cisplatin—esophageal cancer	0.000621	0.0017	CcSEcCtD
Zalcitabine—Pharyngitis—Capecitabine—esophageal cancer	0.000621	0.0017	CcSEcCtD
Zalcitabine—Oedema—Cisplatin—esophageal cancer	0.000603	0.00165	CcSEcCtD
Zalcitabine—Visual impairment—Capecitabine—esophageal cancer	0.000603	0.00165	CcSEcCtD
Zalcitabine—Infection—Cisplatin—esophageal cancer	0.000599	0.00164	CcSEcCtD
Zalcitabine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00059	0.00161	CcSEcCtD
Zalcitabine—Tachycardia—Cisplatin—esophageal cancer	0.000588	0.00161	CcSEcCtD
Zalcitabine—Skin disorder—Cisplatin—esophageal cancer	0.000586	0.0016	CcSEcCtD
Zalcitabine—Eye disorder—Capecitabine—esophageal cancer	0.000585	0.0016	CcSEcCtD
Zalcitabine—Tinnitus—Capecitabine—esophageal cancer	0.000583	0.0016	CcSEcCtD
Zalcitabine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000583	0.00159	CcSEcCtD
Zalcitabine—Flushing—Capecitabine—esophageal cancer	0.000581	0.00159	CcSEcCtD
Zalcitabine—Eosinophilia—Methotrexate—esophageal cancer	0.000576	0.00158	CcSEcCtD
Zalcitabine—Anorexia—Cisplatin—esophageal cancer	0.000575	0.00157	CcSEcCtD
Zalcitabine—Pancreatitis—Methotrexate—esophageal cancer	0.00057	0.00156	CcSEcCtD
Zalcitabine—Chills—Capecitabine—esophageal cancer	0.000561	0.00154	CcSEcCtD
Zalcitabine—Arrhythmia—Capecitabine—esophageal cancer	0.000559	0.00153	CcSEcCtD
Zalcitabine—Alopecia—Capecitabine—esophageal cancer	0.000553	0.00151	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000549	0.0015	CcSEcCtD
Zalcitabine—Neutropenia—Methotrexate—esophageal cancer	0.000544	0.00149	CcSEcCtD
Zalcitabine—Dysuria—Methotrexate—esophageal cancer	0.000544	0.00149	CcSEcCtD
Zalcitabine—Dyspnoea—Cisplatin—esophageal cancer	0.000537	0.00147	CcSEcCtD
Zalcitabine—Flatulence—Capecitabine—esophageal cancer	0.000537	0.00147	CcSEcCtD
Zalcitabine—Dysgeusia—Capecitabine—esophageal cancer	0.000533	0.00146	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000531	0.00145	CcSEcCtD
Zalcitabine—Back pain—Capecitabine—esophageal cancer	0.000527	0.00144	CcSEcCtD
Zalcitabine—Decreased appetite—Cisplatin—esophageal cancer	0.000524	0.00143	CcSEcCtD
Zalcitabine—Muscle spasms—Capecitabine—esophageal cancer	0.000524	0.00143	CcSEcCtD
Zalcitabine—Depression—Methotrexate—esophageal cancer	0.000517	0.00141	CcSEcCtD
Zalcitabine—Pain—Cisplatin—esophageal cancer	0.000516	0.00141	CcSEcCtD
Zalcitabine—Vision blurred—Capecitabine—esophageal cancer	0.000513	0.0014	CcSEcCtD
Zalcitabine—Tremor—Capecitabine—esophageal cancer	0.00051	0.0014	CcSEcCtD
Zalcitabine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000505	0.00138	CcSEcCtD
Zalcitabine—Anaemia—Capecitabine—esophageal cancer	0.000503	0.00138	CcSEcCtD
Zalcitabine—Feeling abnormal—Cisplatin—esophageal cancer	0.000497	0.00136	CcSEcCtD
Zalcitabine—Malaise—Capecitabine—esophageal cancer	0.000491	0.00134	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—esophageal cancer	0.000489	0.00134	CcSEcCtD
Zalcitabine—Vertigo—Capecitabine—esophageal cancer	0.000489	0.00134	CcSEcCtD
Zalcitabine—Syncope—Capecitabine—esophageal cancer	0.000488	0.00134	CcSEcCtD
Zalcitabine—Leukopenia—Capecitabine—esophageal cancer	0.000487	0.00133	CcSEcCtD
Zalcitabine—Palpitations—Capecitabine—esophageal cancer	0.000481	0.00132	CcSEcCtD
Zalcitabine—Loss of consciousness—Capecitabine—esophageal cancer	0.000479	0.00131	CcSEcCtD
Zalcitabine—Body temperature increased—Cisplatin—esophageal cancer	0.000477	0.0013	CcSEcCtD
Zalcitabine—Cough—Capecitabine—esophageal cancer	0.000475	0.0013	CcSEcCtD
Zalcitabine—Hypertension—Capecitabine—esophageal cancer	0.00047	0.00129	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—esophageal cancer	0.000466	0.00127	CcSEcCtD
Zalcitabine—Arthralgia—Capecitabine—esophageal cancer	0.000464	0.00127	CcSEcCtD
Zalcitabine—Myalgia—Capecitabine—esophageal cancer	0.000464	0.00127	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—esophageal cancer	0.000462	0.00126	CcSEcCtD
Zalcitabine—Anxiety—Capecitabine—esophageal cancer	0.000462	0.00126	CcSEcCtD
Zalcitabine—Discomfort—Capecitabine—esophageal cancer	0.000458	0.00125	CcSEcCtD
Zalcitabine—Dry mouth—Capecitabine—esophageal cancer	0.000453	0.00124	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—esophageal cancer	0.000449	0.00123	CcSEcCtD
Zalcitabine—Confusional state—Capecitabine—esophageal cancer	0.000448	0.00123	CcSEcCtD
Zalcitabine—Oedema—Capecitabine—esophageal cancer	0.000444	0.00122	CcSEcCtD
Zalcitabine—Hypersensitivity—Cisplatin—esophageal cancer	0.000444	0.00122	CcSEcCtD
Zalcitabine—Infection—Capecitabine—esophageal cancer	0.000442	0.00121	CcSEcCtD
Zalcitabine—Shock—Capecitabine—esophageal cancer	0.000437	0.0012	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—esophageal cancer	0.000435	0.00119	CcSEcCtD
Zalcitabine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000435	0.00119	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—esophageal cancer	0.000434	0.00119	CcSEcCtD
Zalcitabine—Tachycardia—Capecitabine—esophageal cancer	0.000434	0.00119	CcSEcCtD
Zalcitabine—Asthenia—Cisplatin—esophageal cancer	0.000433	0.00118	CcSEcCtD
Zalcitabine—Skin disorder—Capecitabine—esophageal cancer	0.000432	0.00118	CcSEcCtD
Zalcitabine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00043	0.00118	CcSEcCtD
Zalcitabine—Anorexia—Capecitabine—esophageal cancer	0.000424	0.00116	CcSEcCtD
Zalcitabine—Chills—Methotrexate—esophageal cancer	0.000418	0.00114	CcSEcCtD
Zalcitabine—Diarrhoea—Cisplatin—esophageal cancer	0.000412	0.00113	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—esophageal cancer	0.000411	0.00113	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000405	0.00111	CcSEcCtD
Zalcitabine—Insomnia—Capecitabine—esophageal cancer	0.000402	0.0011	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—esophageal cancer	0.000397	0.00109	CcSEcCtD
Zalcitabine—Dyspnoea—Capecitabine—esophageal cancer	0.000396	0.00108	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—esophageal cancer	0.000392	0.00107	CcSEcCtD
Zalcitabine—Dyspepsia—Capecitabine—esophageal cancer	0.000391	0.00107	CcSEcCtD
Zalcitabine—Decreased appetite—Capecitabine—esophageal cancer	0.000386	0.00106	CcSEcCtD
Zalcitabine—Vomiting—Cisplatin—esophageal cancer	0.000383	0.00105	CcSEcCtD
Zalcitabine—Fatigue—Capecitabine—esophageal cancer	0.000383	0.00105	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—esophageal cancer	0.000382	0.00105	CcSEcCtD
Zalcitabine—Rash—Cisplatin—esophageal cancer	0.00038	0.00104	CcSEcCtD
Zalcitabine—Pain—Capecitabine—esophageal cancer	0.00038	0.00104	CcSEcCtD
Zalcitabine—Dermatitis—Cisplatin—esophageal cancer	0.00038	0.00104	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000376	0.00103	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—esophageal cancer	0.000375	0.00102	CcSEcCtD
Zalcitabine—Feeling abnormal—Capecitabine—esophageal cancer	0.000366	0.001	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—esophageal cancer	0.000366	0.001	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—esophageal cancer	0.000364	0.000996	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000363	0.000994	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—esophageal cancer	0.000363	0.000993	CcSEcCtD
Zalcitabine—Cough—Methotrexate—esophageal cancer	0.000354	0.000968	CcSEcCtD
Zalcitabine—Urticaria—Capecitabine—esophageal cancer	0.000353	0.000966	CcSEcCtD
Zalcitabine—Abdominal pain—Capecitabine—esophageal cancer	0.000351	0.000961	CcSEcCtD
Zalcitabine—Body temperature increased—Capecitabine—esophageal cancer	0.000351	0.000961	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—esophageal cancer	0.000351	0.000961	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—esophageal cancer	0.000345	0.000944	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—esophageal cancer	0.000345	0.000944	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—esophageal cancer	0.000341	0.000933	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—esophageal cancer	0.000334	0.000913	CcSEcCtD
Zalcitabine—Infection—Methotrexate—esophageal cancer	0.000329	0.000899	CcSEcCtD
Zalcitabine—Hypersensitivity—Capecitabine—esophageal cancer	0.000327	0.000896	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000324	0.000886	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—esophageal cancer	0.000321	0.000879	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00032	0.000875	CcSEcCtD
Zalcitabine—Asthenia—Capecitabine—esophageal cancer	0.000319	0.000872	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—esophageal cancer	0.000315	0.000863	CcSEcCtD
Zalcitabine—Pruritus—Capecitabine—esophageal cancer	0.000314	0.00086	CcSEcCtD
Zalcitabine—Diarrhoea—Capecitabine—esophageal cancer	0.000304	0.000832	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000301	0.000825	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—esophageal cancer	0.000299	0.000819	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—esophageal cancer	0.000295	0.000807	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—esophageal cancer	0.000294	0.000805	CcSEcCtD
Zalcitabine—Dizziness—Capecitabine—esophageal cancer	0.000294	0.000804	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—esophageal cancer	0.000291	0.000797	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—esophageal cancer	0.000288	0.000787	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—esophageal cancer	0.000285	0.00078	CcSEcCtD
Zalcitabine—Pain—Methotrexate—esophageal cancer	0.000283	0.000774	CcSEcCtD
Zalcitabine—Vomiting—Capecitabine—esophageal cancer	0.000283	0.000773	CcSEcCtD
Zalcitabine—Rash—Capecitabine—esophageal cancer	0.00028	0.000767	CcSEcCtD
Zalcitabine—Dermatitis—Capecitabine—esophageal cancer	0.00028	0.000766	CcSEcCtD
Zalcitabine—Headache—Capecitabine—esophageal cancer	0.000278	0.000762	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—esophageal cancer	0.000273	0.000746	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000271	0.00074	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—esophageal cancer	0.000263	0.000719	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—esophageal cancer	0.000262	0.000715	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—esophageal cancer	0.000262	0.000715	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—esophageal cancer	0.000244	0.000667	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—esophageal cancer	0.000237	0.000649	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—esophageal cancer	0.000234	0.00064	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—esophageal cancer	0.000226	0.000619	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—esophageal cancer	0.000219	0.000598	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—esophageal cancer	0.00021	0.000575	CcSEcCtD
Zalcitabine—Rash—Methotrexate—esophageal cancer	0.000209	0.000571	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—esophageal cancer	0.000208	0.00057	CcSEcCtD
Zalcitabine—Headache—Methotrexate—esophageal cancer	0.000207	0.000567	CcSEcCtD
Zalcitabine—DCK—Metabolism—GAPDH—esophageal cancer	0.000173	0.000656	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000171	0.000652	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CRABP1—esophageal cancer	0.000171	0.00065	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000171	0.00065	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GAPDH—esophageal cancer	0.00017	0.000646	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00017	0.000645	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000169	0.000644	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000169	0.000641	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CRABP1—esophageal cancer	0.000168	0.000641	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000165	0.000629	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000165	0.000628	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GNG7—esophageal cancer	0.000163	0.000619	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000162	0.000616	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000161	0.000614	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000161	0.000611	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GNG7—esophageal cancer	0.00016	0.000609	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000159	0.000606	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000157	0.000596	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000155	0.000588	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALDH2—esophageal cancer	0.000152	0.00058	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALDH2—esophageal cancer	0.00015	0.000571	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000146	0.000554	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTT1—esophageal cancer	0.000145	0.000551	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000144	0.000547	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2A6—esophageal cancer	0.000143	0.000545	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000143	0.000545	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTT1—esophageal cancer	0.000143	0.000543	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2A6—esophageal cancer	0.000141	0.000537	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000138	0.000524	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000138	0.000523	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000137	0.000519	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ENO1—esophageal cancer	0.000136	0.000517	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS1—esophageal cancer	0.000136	0.000517	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000136	0.000517	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.000135	0.000515	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.000135	0.000515	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000135	0.000512	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PSME2—esophageal cancer	0.000134	0.000509	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PSME1—esophageal cancer	0.000134	0.000509	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS1—esophageal cancer	0.000134	0.000509	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ENO1—esophageal cancer	0.000134	0.000509	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PSME1—esophageal cancer	0.000132	0.000501	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PSME2—esophageal cancer	0.000132	0.000501	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000132	0.000501	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.00013	0.000493	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000128	0.000488	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000128	0.000486	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000127	0.000482	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000119	0.000452	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1B1—esophageal cancer	0.000116	0.000439	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000115	0.000438	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA1—esophageal cancer	0.000115	0.000438	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1B1—esophageal cancer	0.000114	0.000433	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000113	0.00043	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000112	0.000425	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP19A1—esophageal cancer	0.000109	0.000413	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP19A1—esophageal cancer	0.000107	0.000407	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000106	0.000403	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA2—esophageal cancer	0.000105	0.0004	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000101	0.000382	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—HMOX1—esophageal cancer	9.91e-05	0.000377	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLCE1—esophageal cancer	9.79e-05	0.000372	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ADH7—esophageal cancer	9.79e-05	0.000372	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC52A3—esophageal cancer	9.79e-05	0.000372	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BLVRB—esophageal cancer	9.79e-05	0.000372	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—HMOX1—esophageal cancer	9.76e-05	0.000371	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.65e-05	0.000367	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ABCB1—esophageal cancer	9.52e-05	0.000362	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ABCB1—esophageal cancer	9.37e-05	0.000356	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.2e-05	0.00035	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	9.01e-05	0.000342	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.9e-05	0.000338	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	8.88e-05	0.000338	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ADH1B—esophageal cancer	8.58e-05	0.000326	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	8.47e-05	0.000322	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	8.35e-05	0.000318	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA1—esophageal cancer	8.32e-05	0.000316	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC10A2—esophageal cancer	8.32e-05	0.000316	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TYMP—esophageal cancer	8.2e-05	0.000312	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP26A1—esophageal cancer	7.98e-05	0.000303	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALOX15—esophageal cancer	7.78e-05	0.000296	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.76e-05	0.000295	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA2—esophageal cancer	7.61e-05	0.000289	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTO1—esophageal cancer	7.42e-05	0.000282	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TPI1—esophageal cancer	7.42e-05	0.000282	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALDOB—esophageal cancer	7.11e-05	0.00027	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLCE1—esophageal cancer	7.08e-05	0.000269	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADH7—esophageal cancer	7.08e-05	0.000269	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	6.96e-05	0.000265	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BLVRB—esophageal cancer	6.96e-05	0.000265	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	6.9e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BLVRB—esophageal cancer	6.9e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GAPDH—esophageal cancer	6.85e-05	0.00026	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CRABP1—esophageal cancer	6.79e-05	0.000258	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GNG7—esophageal cancer	6.45e-05	0.000245	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.45e-05	0.000245	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CREBBP—esophageal cancer	6.36e-05	0.000242	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CREBBP—esophageal cancer	6.26e-05	0.000238	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADH1B—esophageal cancer	6.21e-05	0.000236	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.17e-05	0.000235	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALDH2—esophageal cancer	6.05e-05	0.00023	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TYMP—esophageal cancer	5.93e-05	0.000225	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	5.92e-05	0.000225	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA1—esophageal cancer	5.92e-05	0.000225	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA1—esophageal cancer	5.87e-05	0.000223	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	5.87e-05	0.000223	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP26A1—esophageal cancer	5.77e-05	0.000219	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTT1—esophageal cancer	5.75e-05	0.000219	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NOS3—esophageal cancer	5.69e-05	0.000217	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2A6—esophageal cancer	5.69e-05	0.000216	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALOX15—esophageal cancer	5.62e-05	0.000214	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NOS3—esophageal cancer	5.61e-05	0.000213	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA2—esophageal cancer	5.41e-05	0.000206	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ENO1—esophageal cancer	5.39e-05	0.000205	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS1—esophageal cancer	5.39e-05	0.000205	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA2—esophageal cancer	5.37e-05	0.000204	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTO1—esophageal cancer	5.36e-05	0.000204	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TPI1—esophageal cancer	5.36e-05	0.000204	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSME2—esophageal cancer	5.31e-05	0.000202	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSME1—esophageal cancer	5.31e-05	0.000202	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.24e-05	0.000199	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—esophageal cancer	5.21e-05	0.000198	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDOB—esophageal cancer	5.14e-05	0.000196	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—esophageal cancer	5.13e-05	0.000195	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADH7—esophageal cancer	5.03e-05	0.000191	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLCE1—esophageal cancer	5.03e-05	0.000191	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLCE1—esophageal cancer	4.99e-05	0.00019	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADH7—esophageal cancer	4.99e-05	0.00019	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GAPDH—esophageal cancer	4.95e-05	0.000188	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.93e-05	0.000187	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CRABP1—esophageal cancer	4.91e-05	0.000187	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GNG7—esophageal cancer	4.67e-05	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1B1—esophageal cancer	4.58e-05	0.000174	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.55e-05	0.000173	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.55e-05	0.000173	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.41e-05	0.000168	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADH1B—esophageal cancer	4.37e-05	0.000166	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDH2—esophageal cancer	4.37e-05	0.000166	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—EP300—esophageal cancer	4.33e-05	0.000165	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP19A1—esophageal cancer	4.31e-05	0.000164	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—EP300—esophageal cancer	4.27e-05	0.000162	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TYMP—esophageal cancer	4.22e-05	0.00016	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TYMP—esophageal cancer	4.18e-05	0.000159	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—esophageal cancer	4.16e-05	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	4.11e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	4.1e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	4.07e-05	0.000155	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALOX15—esophageal cancer	4e-05	0.000152	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALOX15—esophageal cancer	3.96e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—esophageal cancer	3.93e-05	0.00015	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ENO1—esophageal cancer	3.9e-05	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS1—esophageal cancer	3.9e-05	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA1—esophageal cancer	3.87e-05	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.87e-05	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSME1—esophageal cancer	3.84e-05	0.000146	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSME2—esophageal cancer	3.84e-05	0.000146	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TPI1—esophageal cancer	3.81e-05	0.000145	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.81e-05	0.000145	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTO1—esophageal cancer	3.78e-05	0.000144	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TPI1—esophageal cancer	3.78e-05	0.000144	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—esophageal cancer	3.77e-05	0.000144	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.66e-05	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDOB—esophageal cancer	3.62e-05	0.000138	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA2—esophageal cancer	3.54e-05	0.000135	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.52e-05	0.000134	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.49e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.49e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.46e-05	0.000131	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNG7—esophageal cancer	3.32e-05	0.000126	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.31e-05	0.000126	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADH7—esophageal cancer	3.29e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.29e-05	0.000125	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNG7—esophageal cancer	3.29e-05	0.000125	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—esophageal cancer	3.2e-05	0.000122	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—esophageal cancer	3.16e-05	0.00012	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.12e-05	0.000118	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.11e-05	0.000118	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.08e-05	0.000117	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.96e-05	0.000112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.93e-05	0.000111	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.92e-05	0.000111	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.9e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.89e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.88e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.84e-05	0.000108	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ENO1—esophageal cancer	2.77e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.77e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.76e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ENO1—esophageal cancer	2.75e-05	0.000104	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.75e-05	0.000104	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSME2—esophageal cancer	2.73e-05	0.000104	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSME1—esophageal cancer	2.73e-05	0.000104	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.73e-05	0.000104	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSME1—esophageal cancer	2.71e-05	0.000103	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSME2—esophageal cancer	2.71e-05	0.000103	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.68e-05	0.000102	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.61e-05	9.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.52e-05	9.59e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.49e-05	9.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.49e-05	9.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.39e-05	9.09e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.36e-05	8.99e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.36e-05	8.96e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.34e-05	8.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.3e-05	8.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.28e-05	8.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NOS3—esophageal cancer	2.26e-05	8.59e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.22e-05	8.42e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.2e-05	8.35e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNG7—esophageal cancer	2.17e-05	8.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.07e-05	7.86e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.03e-05	7.73e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.02e-05	7.69e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—esophageal cancer	2e-05	7.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.97e-05	7.47e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.94e-05	7.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.93e-05	7.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.92e-05	7.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.91e-05	7.27e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.82e-05	6.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.81e-05	6.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.81e-05	6.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.79e-05	6.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.79e-05	6.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—EP300—esophageal cancer	1.72e-05	6.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NOS3—esophageal cancer	1.63e-05	6.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.54e-05	5.86e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.49e-05	5.68e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.45e-05	5.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.45e-05	5.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.32e-05	5.03e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.3e-05	4.93e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.29e-05	4.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.27e-05	4.83e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.27e-05	4.82e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—EP300—esophageal cancer	1.24e-05	4.72e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.16e-05	4.41e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.15e-05	4.38e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.06e-05	4.04e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.05e-05	4e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	9.19e-06	3.49e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—EP300—esophageal cancer	8.83e-06	3.36e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—EP300—esophageal cancer	8.76e-06	3.33e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.48e-06	3.22e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NOS3—esophageal cancer	7.59e-06	2.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.94e-06	2.64e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	6.53e-06	2.48e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	6.48e-06	2.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—EP300—esophageal cancer	5.77e-06	2.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.27e-06	1.62e-05	CbGpPWpGaD
